Sarepta Therapeutics (FRA:AB3A) FCF Yield % : -4.92 (As of May. 01, 2024)

View and export this data going back to 1997. Start your Free Trial

What is Sarepta Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Sarepta Therapeutics's Trailing 12-Month Free Cash Flow is €-547 Mil, and Market Cap is €11,162 Mil. Therefore, Sarepta Therapeutics's FCF Yield % for today is -4.92%.

The historical rank and industry rank for Sarepta Therapeutics's FCF Yield % or its related term are showing as below:

FRA:AB3A' s FCF Yield % Range Over the Past 10 Years
Min: -31.51 Med: -6.73 Max: 3.7
Current: -4.92

During the past 13 years, the highest FCF Yield % of Sarepta Therapeutics was 3.70%. The lowest was -31.51%. And the median was -6.73%.

FRA:AB3A's FCF Yield % is ranked better than
71.59% of 1552 companies
in the Biotechnology industry
Industry Median: -14.81 vs FRA:AB3A: -4.92

Sarepta Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was -18.57%.

Sarepta Therapeutics FCF Yield % Historical Data

The historical data trend for Sarepta Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sarepta Therapeutics FCF Yield % Chart

Sarepta Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-5.36

0.19

-6.14

-3.24

-6.53

Sarepta Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-3.64	-7.07	-5.40	-5.35	-3.27

Competitive Comparison of Sarepta Therapeutics's FCF Yield %

For the Biotechnology subindustry, Sarepta Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sarepta Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sarepta Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Sarepta Therapeutics's FCF Yield % falls into.

Sarepta Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Sarepta Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-539.506	/	8255.896944
	=	-6.53%

Sarepta Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-67.579	*	4	/	8255.896944
	=	-3.27%

Sarepta Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Sarepta Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Sarepta Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sarepta Therapeutics (FRA:AB3A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (FRA:AB3A) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

SRPT:USA AB3A:Germany S1RP34:Brazil

Address

215 First Street, Suite 415, Cambridge, MA, USA, 02142

Website

https://www.sarepta.com

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Sarepta Therapeutics (FRA:AB3A) Headlines

No Headlines